Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DNLI | NVCR | JANX | ||
| Company | Denali Therapeutics Inc | Novocure Ltd Ord Sh | Janux Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 21.36 | 30.33 | 56.37 | ||
| High | 22.21 | 31.52 | 59.72 | ||
| Low | 21.00 | 30.33 | 55.63 | ||
| Last | 21.45 | 30.80 | 56.83 | ||
| Change | -0.04 | +0.40 | +0.08 | ||
| % Change | -0.19% | +1.32% | +0.14% | ||
| Volume | 2,810,600 | 1,820,700 | 1,251,800 | ||
| 20-Day Average Volume | 965,450 | 1,948,210 | 1,687,815 | ||
| Previous Close | 21.49 | 30.40 | 56.75 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 23.81 | 27.39 | 56.84 | ||
| 20-Day Raw Stochastic | 12.73% | 80.45% | 53.05% | ||
| 20-Day Relative Strength | 35.36% | 64.80% | 52.16% | ||
| Weighted Alpha | -9.00 | +93.99 | -4.98 | ||
| Today's Opinion | 40% Sell | 100% Buy | 88% Buy | ||
| Previous Opinion | 40% Sell | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 24% Buy | 24% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.62% since 12/13/24 | -7.81% since 12/13/24 | -7.00% since 12/13/24 | ||
| Low | 20.76 on 12/19/24 | 29.79 on 12/19/24 | 54.20 on 12/19/24 | ||
| High | 24.15 on 12/16/24 | 34.13 on 12/18/24 | 63.00 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | -12.16% since 11/20/24 | +82.68% since 11/20/24 | +16.07% since 11/20/24 | ||
| Low | 20.76 on 12/19/24 | 16.30 on 11/21/24 | 40.02 on 12/02/24 | ||
| High | 26.18 on 12/09/24 | 34.13 on 12/18/24 | 71.71 on 12/05/24 | ||
| 3-Month | |||||
| %Chg | -30.60% since 09/20/24 | +76.50% since 09/20/24 | +13.21% since 09/20/24 | ||
| Low | 20.76 on 12/19/24 | 14.17 on 10/08/24 | 40.02 on 12/02/24 | ||
| High | 33.33 on 11/11/24 | 34.13 on 12/18/24 | 71.71 on 12/05/24 | ||
| 6-Month | |||||
| %Chg | +0.23% since 06/20/24 | +60.63% since 06/20/24 | +41.02% since 06/20/24 | ||
| Low | 19.74 on 08/05/24 | 14.17 on 10/08/24 | 34.51 on 08/08/24 | ||
| High | 33.33 on 11/11/24 | 34.13 on 12/18/24 | 71.71 on 12/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,087,127 | 3,332,590 | 2,982,552 | ||
| Shares Outstanding, K | 143,922 | 108,201 | 52,482 | ||
| Annual Sales | 330,530,000 | 509,340,000 | 8,080,000 | ||
| Annual Net Income | -145,220,000 | -207,040,000 | -58,290,000 | ||
| Last Quarter Sales | 0 | 155,100,000 | 440,000 | ||
| Last Quarter Net Income | -107,190,000 | -30,570,000 | -28,060,000 | ||
| 60-Month Beta | 1.35 | 0.75 | 3.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.63 on 11/06/24 | -0.28 on 10/30/24 | -0.51 on 11/06/24 | ||
| Latest Earnings Date | 11/05/24 | 10/30/24 | 11/05/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||